Gland Pharma promoter Fosun divests 6 percent stake for Rs 1,754 crore
Written By : Ruchika Sharma
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2024-06-20 09:18 GMT | Update On 2024-06-20 09:18 GMT
Advertisement
Fosun Pharma, a promoter in Gland Pharma, has executed a significant divestment by selling a 6 per cent stake for Rs 1,754 crore through an open market transaction.
The transaction, handled by its subsidiary Fosun Pharma Industrial Pte, offloaded the shares of Hyderabad-based Gland Pharma through a bulk deal on the BSE.
According to the bulk deal data available on the BSE, Fosun Pharma Industrial Pte disposed of 99 lakh shares or a 6 per cent stake in Gland Pharma.
The shares were sold at an average price of Rs 1,771.81 apiece, taking the deal size to Rs 1,754.09 crore, as per a PTI report.
After the stake sale, Fosun Pharma's shareholding in Gland Pharma has declined to 51.86 per cent from 57.86 per cent.
Meanwhile, UBS Principal Capital Asia picked up 8.25 lakh shares, amounting to a 0.5 per cent stake in Gland Pharma.
The shares were purchased at an average price of Rs 1,771.05 per piece, taking the transaction value to Rs 146.11 crore.
Details of the other buyers of Gland Pharma's shares could not be ascertained.
In October 2017, Fosun Pharma acquired approximately 74 per cent of Gland Pharma at a valuation of not more than $1.09 billion
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.